Skip to main content
. 2020 Jan 3;22(2):23. doi: 10.1208/s12248-019-0401-3

Table II.

Population Parameter Estimates for the TMDD Model

Parameter Units Description Estimate (RSE%) IIV
CLA L/day Clearance of antibody 0.999 (9) 42.5 (0.08)
VC L Central volume of distribution 1.10 (7) 7.3 (22)
VP L Peripheral volume of distribution 5.28 (22)
Q L/day Inter-compartmental clearance 1.1a
F % Subcutaneous bioavailability 50a
kA Day−1 Subcutaneous absorption rate 0.211 (8) 31.3 (7)
CLSR L/day Clearance of sIL7Rα 2.24 (23)
VR L Volume of sIL7Rα = VC
CLC1 L/day Clearance of the mAb:sIL7Rα complex 0.196 (21)
KD1 nM Dissociation constant of mAb:sIL7Rα 0.779 (59)
BLSR nM Baseline concentration of sIL7Rα 0.45 (14) 35.1 (0)
CLCR L/day Clearance of the cIL7Rα 10.4 (26)
CLC2 L/day Clearance of the mAb:cIL7Rα complex = CLCR
KD2 nM Dissociation constant of mAb:cIL7Rα 0.450 (20)
BLCR nM Baseline concentration of cIL7Rα 1.37 (13)
Residual error (ε)
  σ1 % Proportional error, PK 0.434 (6)
  σ2 % Additive error, RO 18.2 (30)
  σ3 % Proportional error, sIL7Rα 0.150 (8)

RSE relative standard error, IIV interindividual variability expressed as % coefficient of variation (% η-shrinkage), sIL7Rα soluble IL7 receptor α, cIL7Rα IL7 receptor α on T cells, mAb monoclonal antibody. Dashes indicate data not computed

aFixed to the typical value estimated from healthy volunteers administered SC or IV PF-06342674